false
OasisLMS
Catalog
CHEST 2023 On Demand Pass
The Peripheral Lung Nodule: Where Are We Now?
The Peripheral Lung Nodule: Where Are We Now?
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Lung cancer screening with low-dose CT has been shown to reduce mortality, but there are still barriers that need to be addressed to improve screening rates and adherence to follow-up. The USPSTF recommends screening individuals aged 50 to 80 with a 20-pack-year smoking history or greater, and if they quit, quit within 15 years. However, there is uncertainty about the relevance of screening in the general population, as the benefits may be different in individuals with more comorbidities and competing causes of death. Socioeconomic factors also play a role in disparities in lung cancer screening, and it is important to address access to care. Currently, only 5.8% of eligible individuals are being screened in the US. Adherence to annual screening and follow-up after a positive CT is essential for maximizing the benefits of screening. Strategies to address these barriers include community outreach, telehealth, and mobile technologies, but a centralized lung cancer screening approach may be particularly effective. A centralized approach can improve rates of screening and adherence, and involves a multidisciplinary team to manage the screening process and make decisions regarding diagnostic procedures. In summary, lung cancer screening saves lives, but efforts are needed to overcome barriers and improve screening rates and adherence.
Meta Tag
Category
Lung Cancer
Session ID
1163
Speaker
Alexander Chen
Speaker
M. Patricia Rivera
Speaker
Anil Vachani
Speaker
Momen Wahidi
Track
Lung Cancer
Keywords
lung cancer screening
low-dose CT
mortality reduction
barriers
screening rates
follow-up adherence
USPSTF recommendations
comorbidities
socioeconomic factors
×
Please select your language
1
English